盗墓笔记小说,天下高月小说

血管內(nèi)皮生長因子C(VEGFC)真核蛋白

Eukaryotic Vascular Endothelial Growth Factor C (VEGFC)

VEGF-C; Flt4-L; VRPL; Vascular Endothelial Growth Factor-Related Protein

編號EPA145Hu63
物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 所有
- 人
- 小鼠
- 大鼠
- 豚鼠
- 家兔
- 獼猴
- 山羊
- 綿羊
- 馬
- 牛
- 豬
- 雞
- 狗
- 其他物種
- 多物種
- 泛物種
來源真核表達
宿主293F cell
內(nèi)毒素水平<1.0EU/µg(LAL法測定)
亞細胞定位分泌
預(yù)測分子量21.7kDa
實際分子量20kDa(差異分析請參閱說明書)
片段與標簽Thr103~Arg227 with N-terminal His Tag
緩沖液成份PBS, pH7.4, containing 5% Trehalose.
性狀凍干粉
純度> 90%
等電點8.4
應(yīng)用 Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。
下載英文說明書中文說明書
規(guī)格 10μg50μg 200μg 1mg 5mg
價格 ¥ 972 2430 ¥ 2430 ¥ 4860 ¥ 14580 ¥ 36450
欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!

產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)

Figure. SDS-PAGE

通過ISO 9001、ISO 13485質(zhì)量體系認證

序列

用法

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

儲存

避免反復(fù)凍融。2-8°C不超過一個月，-80°C不超過12個月。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。

贈品

聚丙烯酰胺凝膠電泳(PAGE)實驗服務(wù)

增值服務(wù)

BCA蛋白定量檢測試劑盒
 蛋白標記定制服務(wù)
蛋白分子量MARKER
單克隆抗體定制服務(wù)
多克隆抗體定制服務(wù)
蛋白活性測定實驗服務(wù)
免疫沉淀(IP)實驗服務(wù)
電泳遷移率變動分析(EMSA)實驗服務(wù)
緩沖液
 慢病毒包裝實驗服務(wù)
腺病毒包裝實驗服務(wù)
實時熒光定量PCR實驗服務(wù)
棘突蛋白受體結(jié)合結(jié)構(gòu)域
 蛋白G
蛋白 A

相關(guān)產(chǎn)品

編號	適用物種：Homo sapiens (Human，人)	應(yīng)用(僅供研究使用，不用于臨床診斷！)
APA145Hu61	血管內(nèi)皮生長因子C(VEGFC)活性蛋白	Cell?culture;?Activity?Assays.
RPA145Hu01	血管內(nèi)皮生長因子C(VEGFC)重組蛋白	Positive Control; Immunogen; SDS-PAGE; WB.
RPA145Hu02	血管內(nèi)皮生長因子C(VEGFC)重組蛋白	Positive Control; Immunogen; SDS-PAGE; WB.
EPA145Hu62	血管內(nèi)皮生長因子C(VEGFC)真核蛋白	Positive Control; Immunogen; SDS-PAGE; WB.
EPA145Hu63	血管內(nèi)皮生長因子C(VEGFC)真核蛋白	Positive Control; Immunogen; SDS-PAGE; WB.
EPA145Hu61	血管內(nèi)皮生長因子C(VEGFC)真核蛋白	Positive Control; Immunogen; SDS-PAGE; WB.
APA145Hu01	血管內(nèi)皮生長因子C(VEGFC)活性蛋白	Cell?culture;?Activity?Assays.
PAA145Hu01	血管內(nèi)皮生長因子C(VEGFC)多克隆抗體	WB; IHC; ICC; IP.
MAA145Hu23	血管內(nèi)皮生長因子C(VEGFC)單克隆抗體	WB; IHC; ICC; IP.
MAA145Hu24	血管內(nèi)皮生長因子C(VEGFC)單克隆抗體	WB; IHC; ICC; IP.
MAA145Hu22	血管內(nèi)皮生長因子C(VEGFC)單克隆抗體	WB; IHC; ICC; IP.
MAA145Hu21	血管內(nèi)皮生長因子C(VEGFC)單克隆抗體	WB; IHC; ICC; IP.
MEA145Hu	血管內(nèi)皮生長因子C(VEGFC)檢測試劑盒(酶聯(lián)免疫吸附試驗法,小樣本)	Enzyme-linked immunosorbent assay for Antigen Detection.
SEA145Hu	血管內(nèi)皮生長因子C(VEGFC)檢測試劑盒(酶聯(lián)免疫吸附試驗法)	Enzyme-linked immunosorbent assay for Antigen Detection.
SCA145Hu	血管內(nèi)皮生長因子C(VEGFC)檢測試劑盒(化學(xué)發(fā)光免疫分析法)	Chemiluminescent immunoassay for Antigen Detection.
LMA145Hu	血管內(nèi)皮生長因子C(VEGFC)等多因子檢測試劑盒(流式熒光發(fā)光法)	FLIA Kit for Antigen Detection.
KSA145Hu01	血管內(nèi)皮生長因子C(VEGFC)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法)	Main materials for "Do It (ELISA Kit) Yourself".

參考文獻

雜志	參考文獻
Journal of Cellular Biochemistry	Alternatively activated RAW264. 7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma [PubMed: 19241443]
genetics and molecular research	Expression of COX-2 and VEGF-C in cholangiocarcinomas at different clinical and pathological stages [PubMed: 26125824]
Experimental and Therapeutic	Fenofibrate inhibits the expression of VEGFC and VEGFR-3 in retinal pigmental epithelial cells exposed to hypoxia [PubMed: 26622498]
Am J Pathol	IL-10 Indirectly Regulates Corneal Lymphangiogenesis and Resolution of Inflammation via Macrophages [PubMed: 26608451]
PLoS One.	Interleukin-6 Induces Vascular Endothelial Growth Factor-C Expression via Src-FAK-STAT3 Signaling in Lymphatic Endothelial Cells. [pubmed:27383632]
Oncology?Letters	RNAi-mediated?gene?silencing?of?vascular?endothelial?growth?factor?C?suppresses?growth?andinduces?apoptosis?in?mouse?breast?cancer?in?vitro?and in?vivo. [pubmed:27895746]
Angiogenesis	Characterization of isolated liver sinusoidal endothelial cells for liver bioengineering [Pubmed:29582235]
Oncology Reports	Effects of diphyllin as a novel V-ATPase inhibitor on TE-1 and ECA-109 cells [Pubmed:29328465]
LABORATORY INVESTIGATION	Dynamic signature of lymphangiogenesis during acute kidney injury and chronic kidney disease [Pubmed: 31019289]
Cutaneous and Ocular Toxicology	Isotretinoin does not alter VEGF-A and VEGF-C levels: Do retinoids behave differently in dose-dependent and/or in vivo/in vitro conditions? [Pubmed: 32722957]

留言咨詢